相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of a Preclinical PK/PD Model to Assess Antitumor Response of a Sequential Aflibercept and Doxorubicin-Dosing Strategy in Acute Myeloid Leukemia
Gerald J. Fetterly et al.
AAPS JOURNAL (2013)
Anthracycline cardiotoxicity
Pierantonio Menna et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes-A Report From the Children's Oncology Group
Javier G. Blanco et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Acute leukemias in children with Down syndrome
Laura Seewald et al.
MOLECULAR GENETICS AND METABOLISM (2012)
MicroRNAs Differentially Regulate Carbonyl Reductase 1 (CBR1) Gene Expression Dependent on the Allele Status of the Common Polymorphic Variant rs9024
James L. Kalabus et al.
PLOS ONE (2012)
Functional characterization of drug uptake and metabolism in the heart
Michael Weiss
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Down syndrome: National conference on patient registries, research databases, and biobanks
Mary Lou Oster-Granite et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Down syndrome: Issues to consider in a national registry, research database and biobank
Linda L. McCabe et al.
MOLECULAR GENETICS AND METABOLISM (2011)
What's Up With Down Syndrome and Leukemia-A Lot!
Jeffrey W. Taub et al.
PEDIATRIC BLOOD & CANCER (2011)
Pharmacogenetics of Target Genes Across Doxorubicin Disposition Pathway: A Review
Suman Lal et al.
CURRENT DRUG METABOLISM (2010)
Expression of the Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 in Hearts from Donors with Down Syndrome
James L. Kalabus et al.
DRUG METABOLISM AND DISPOSITION (2010)
Naturally Occurring Variants of Human Aldo-Keto Reductases with Reduced In Vitro Metabolism of Daunorubicin and Doxorubicin
Onkar S. Bains et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Pharmacogenetics of Human Carbonyl Reductase 1 (CBR1) in Livers from Black and White Donors
Vanessa Gonzalez-Covarrubias et al.
DRUG METABOLISM AND DISPOSITION (2009)
Molecular genetic analysis of Down syndrome
David Patterson
HUMAN GENETICS (2009)
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:Quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
Javier G. Blanco et al.
CANCER (2008)
Cardiotoxicity of antitumor drugs
Pierantonio Menna et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Two allelic variants of aldo-keto reductase 1A1 exhibit reduced in vitro metabolism of daunorubicin
Onkar S. Bains et al.
DRUG METABOLISM AND DISPOSITION (2008)
Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver
Nina Kassner et al.
DRUG METABOLISM AND DISPOSITION (2008)
Cardiomyopathy in children with down syndrome treated for acute myeloid leukemia: A report from the children's oncology group study POG 9421
Maureen M. O'Brien et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1
Takeshi Miura et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Classification of human chromosome 21 gene-expression variations in down syndrome:: Impact on disease phenotypes
E. Ait Yahya-Graison et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms
Trevor M. Penning et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance
Paola Prandini et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Gene expression variation in 'Down syndrome' mice allows prioritization of candidate genes
Marc Sultan et al.
GENOME BIOLOGY (2007)
Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the shortchain dehydrogenase/reductase superfamily
Frank Hoffmann et al.
DRUG METABOLISM REVIEWS (2007)
Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies
KA Wouters et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes
Q Cheng et al.
NATURE GENETICS (2005)
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
SS Lakhman et al.
DRUG METABOLISM AND DISPOSITION (2005)
Human carbonyl reduction pathways and a strategy for their study in vitro
MJC Rosemond et al.
DRUG METABOLISM REVIEWS (2004)
分享论文
